Compounds > thiodigalactoside
Page last updated: 2024-09-03

thiodigalactoside and Mouth Neoplasms

thiodigalactoside has been researched along with Mouth Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernardo, L1
Aggarwal, S; Das, SN1

Other Studies

2 other study(ies) available for thiodigalactoside and Mouth Neoplasms

ArticleYear
Response to Aggarwal and Das, Thiodigalactoside shows antitumour activity by beta-galactoside-binding protein and regulatory T cells inhibition in oral squamous cell carcinoma.
    Oral diseases, 2018, Volume: 24, Issue:4

    Topics: Carcinoma, Squamous Cell; Galactosides; Humans; Mouth Neoplasms; T-Lymphocytes, Regulatory; Thiogalactosides

2018
Thiodigalactoside shows antitumour activity by beta-galactoside-binding protein and regulatory T cells inhibition in oral squamous cell carcinoma.
    Oral diseases, 2016, Volume: 22, Issue:5

    Topics: Angiogenesis Inducing Agents; Apoptosis; Carcinoma, Squamous Cell; CD4-Positive T-Lymphocytes; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Galectins; Head and Neck Neoplasms; Humans; Interleukin-10; Interleukins; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; T-Lymphocytes, Regulatory; Thiogalactosides

2016